Skip to content
type1.science
Phase 2Not yet recruitingNCT07225465

Safe ketone thresholds for dapagliflozin in T1D

Study evaluating ketone thresholds intended to minimize ketosis risk for people with T1D using dapagliflozin.

Primary endpoints

  • Percent time spent with interstitial ketones ≥3.0mmol/L (Main Study)
  • Percent of time spent with interstitial ketones ≥3.0mmol/L during exercise (Exercise Study)

Results so far

No results posted yet.